Antipsychotic prescribing patterns in care homes and relationship with dementia

被引：18

作者：

Alldred, David P. ^{[1
]}

Petty, Duncan R. ^{[2
]}

Bowie, Peter ^{[3
]}

Zermansky, Arnold G. ^{[4
]}

Raynor, David K. ^{[2
]}

机构：

[1] Univ Leeds, Sch Healthcare, Pharm Practice & Med Management Grp, BainesWing, Leeds LS2 9UT, W Yorkshire, England

[2] Univ Leeds, Pharm Practice & Med Management Grp, Leeds, W Yorkshire, England

[3] Older Peoples Mental Hlth Dept, Longley Ctr, Norwood, MA USA

[4] Univ Leeds, Leeds, W Yorkshire, England

来源：

PSYCHIATRIC BULLETIN | 2007年 / 31卷 / 09期

关键词：

D O I：

10.1192/pb.bp.106.012880

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

AIMS AND METHOD To determine the prescribing patterns for antipsychotics in care homes for the elderly, a cross-sectional study was carried out using data from the intervention group of a randomised controlled trial of medication review in care homes. RESULTS Of 331 residents studied, 67 (20%) were prescribed an antipsychotic (70% atypical); 57 of these (85%) did not have a diagnosis of a psychotic disorder. The antipsychotic prescribing rate was 32% (46 out of 146) for those with dementia and 10% (17 out of 174) for those without dementia. A quarter (82 out of 331) had received amedication review by the general practitioner in the preceding 12 months. CLINICAL IMPLICATIONS One-fifth of residents were prescribed an antipsychotic with little evidence of review. Systems should ensure residents' treatment is reviewed regularly.

引用

页码：329 / +

页数：5

共 27 条

[11] Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review [J].

Lee, PE ;

Gill, SS ;

Freedman, M ;

Bronskill, SE ;

Hillmer, MP ;

Rochon, PA .

BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7457) :75-78A

[12]

McGrath AM, 1996, BRIT MED J, V312, P611

[13] Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up [J].

McShane, R ;

Keene, J ;

Gedling, K ;

Fairburn, C ;

Jacoby, R ;

Hope, T .

BMJ-BRITISH MEDICAL JOURNAL, 1997, 314 (7076) :266-270

[14]

MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY, 2001, DISC DROL TABL SUSP

[15]

MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY, 2000, MHRA RESTR US THIOR

[16]

MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY, 2004, AT ANT DRUGS STROK

[17]

MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY, 1999, CURR PROBL PHARM SUS, V25, P1

[18]

Molloy D W, 1997, Int Psychogeriatr, V9 Suppl 1, P87, DOI 10.1017/S1041610297004754

[19] An indicator of appropriate neuroleptic prescribing in nursing homes [J].

Oborne, CA ;

Hooper, R ;

Li, KC ;

Swift, CG ;

Jackson, SHD .

AGE AND AGEING, 2002, 31 (06) :435-439

[20] Neuroleptic prescribing in residents of nursing homes - Geographical differences make extrapolation difficult [J].

Passmore, AP ;

Crawford, VLS ;

Beringer, TRO ;

Fullerton, KJ ;

Mccaffrey, PM .

BRITISH MEDICAL JOURNAL, 1996, 312 (7047) :1667-1667

← 1 2 3 →